Immunotherapy for Pediatric Brain Tumors

Malignant brain tumors are the most common cause of solid cancer death in children. New targeted therapies are vital to improve treatment outcomes, but must be developed to enable trafficking across the blood brain barrier (BBB). Since activated T cells cross the BBB, cancer immunotherapy can be har...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayour, Elias J., Mitchell, Duane A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664064/
https://www.ncbi.nlm.nih.gov/pubmed/29065490
http://dx.doi.org/10.3390/brainsci7100137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664064/
https://www.ncbi.nlm.nih.gov/pubmed/29065490
http://dx.doi.org/10.3390/brainsci7100137

Ejemplares similares